Introduction
Penicillinase-producing gonococci (PPNG) together with their association with failure of penicillin treatment were first reported from Britain in 1976 (Philips, 1976; Percival et al., 1976) . Since then, there have been many such reports. High level of penicillin resistance in non-penicillinase producing strains (non-PPNG) has also been reported recently (Seth and Johnston, 1980) , although their clinical correlation was not clearly demonstrated. Most of these reports came from big cities or areas close to them. It is also known that antibiotic sensitivities of organisms vary from place to place and year to year (Rahman, 1978; Seth, Kolator and Wilkinson, 1979) . The following study was undertaken to assess the penicillin sensitivities of gonococci from this peripheral health district consisting of small towns and villages and to see if there were any clinical correlations with the laboratory-observed'sensitivities.
Materials and methods
Since September 1977, minimum inhibitory concentrations (MIC) of penicillin against all strains of gonococci isolated from this district have been determined, using antibiotic-incorporated agar and an inoculum of 104 colony-forming units approximately. Details of the media and techniques were as described by Seth et al. (1979) . All results were recorded and, for the purpose of this study, results up to the end of 1980 were taken. Penicillin resistance was arbitrarily defined as MIC 0-25 mg/l for this study. Tests were always repeated and results confirmed when high MICs were noted (>0-25 mg/i). All such strains were also tested for penicillinase production as done by Percival et al. (1976) .
Clinical correlationship was judged in a doubleblind way in that MICs were not known to the clinician treating the patients and the outcome of treatment or nature of treatment were not known to the microbiologist until at least 3 weeks after the completion of treatment. Standard treatment of gonorrhoea in absence of complications (such as signs of extragenital or pelvic involvement or abscess) was a single i.m. injection of 2 Mu. of procaine penicillin G with 1 g of probenecid orally. The treatment was extended up to 5 days with a similar daily dose of both drugs in complicated cases or when one-dose treatment failed. For the purpose of this study, penicillin 'success' was recorded for a patient who remained free of signs and symptoms and free of culturable gonococci one week after the completion of treatment. Where penicillin failure was observed, a careful history from each case confirming that no sexual activities occurred during the treatment and follow-up period was also recorded to exclude the possibility of reinfection. Those who could not be followed-up or had other antibiotics (either because of penicillin allergy or presence of other infections) were excluded from this part of the study.
Results
There were 62 penicillin-resistant strains out of 321 strains tested (19-3% resistant) in these years. None was found to be a penicillinase producer. Details of the MICs found in 1977-80 are given in Table 1 . This would show that although there was no significant change in the most frequently observed MICs (0-015-0-03 mg/l) over these years, the proportion of resistant strains had increased after 1977. (Nayyar, Michel and Stolz, 1980; Shtibel, 1980; Seth and Johnston, 1980 in this locality. This was contrary to the experience from another region of the U.K. (Dowsett, 1980) , where resistance was seen in 2-5 %, 10-7 % and 37-3% in 1978, 1979 and 1980 respectively. A few of these strains from that region were penicillinase producers, which have not been found so far in this district. However, a problem in comparing the rate of resistance from several reports arises from the fact that there were either different or no clearcut definitions of 'resistance' (Meheus et al., 1976; Seth et al., 1979; Nayyar et al., 1980) . Some correlations of higher MICs of penicillin with therapeutic failures have been observed before (Holmes et al., 1973) . But the present study has demonstrated that penicillin treatment would be clinically effective in infections with 'penicillinresistant' non-PPNG strains when the MICs of penicillin were < I 0 mg/I. This would not be entirely surprising in the light of recent observations on the pharmacokinetic determinants of the cure of gonorrhoea with penicillin (Jaffe et al., 1979) . After injections of 2-4-4-8 Mu. of procaine penicillin G, serum concentrations of penicillin were expected to be 10-34 mg/l, and higher concentrations would be maintained for several hours if probenecid were also given. Jaffe et al. concluded from their study that the cure of gonococcal urethritis was most likely to occur when serum penicillin concentrations were 3-4 times the MIC of the infecting strain and remained at these levels for 7-10 hr. These conditions would be met if the MIC against the infecting strain was 10 mg/l. However, with the MIC higher than this, the serum concentration of penicillin might have fallen shorter than the required 4 times of the MIC, resulting in therapeutic failures in certain cases. In the present study, penicillin failure was initially seen in 3 out of 4 cases treated with a single dose of penicillin, where MIC against the infecting strains was 2 mg/l. When these 3 failed cases were retreated with a 5-day course, failure was still seen in one patient who was successfully treated with another antibiotic.
For this study, gonococci were called 'penicillinresistant' when the MIC ofpenicillin was > 0 25 mg/l. Other studies have even taken MIC of 0-125 mg/l to mean penicillin-resistance (Seth et al., 1979) . As infections with such strains would be clinically and bacteriologically cured with the currently used high dose of penicillin, it is arguable whether one should call such strains 'penicillin-resistant' unless there is evidence of penicillinase production. There is a need for a more clinically significant definition of penicillin-resistance for gonococci. One final observation which could be made from this study is that penicillin in the currently used high doses is still highly effective in treating gonorrhoea, as has been observed by others (Seth et al., 1979 
